Complement Therapeutics ^Company

Complement Therapeutics is a research and experimental development on biotechnology. It develops a portfolio of treatments for Complement-related diseases, including age-related macular degeneration, each with a high clinical need. Through the research program, they have gained new insights into the ways the Complement System works and how it is dysregulated in age-related macular degeneration. They also develop protein and gene therapies, multiple platforms. The company's pipeline includes perspective medicines against Geographic atrophy ('dry' age-related macular degeneration), kidney diseases, systemic diseases (lupus, ischemic reperfusion injury, Paroxysmal nocturnal hemoglobinuria), inflammation regulation of the brain.